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The clinical management of a patient with systemic fungus in-
fection is dependent upon so many different factors that no
single form of therapy can be recommended for any one mycosis.
Because of variations in response to different types of therapy,
the clinical course must be the chief guide in the treatment of
each patient. It is the purpose of this paper to present immuno-
logic data obtained in a few cases of mycotic infection and to
correlate these findings with the results of various therapeutic
procedures.
It should be emphasized that there are certain fundamental
differences between the reaction of the animal tissues to invasion
by fungi and that produced by viruses or bacteria. Bacteria
and viruses are small-sized and often toxic, frequently causing
acute and severe pathologic changes to which the infected animal
usually responds with the formation of large amounts of easily
detectable antibodies. In contrast, the fungi are larger, much
less toxic and the animal usually responds sluggishly to the in-
fection. The fungi multiply more slowly in the tissues, and being
less antigenic, they do not stimulate the tissues of the infected
animal to rapid antibody formation. Furthermore, because of
the more complex morphology of the fungi in culture, it is more
difficult to prepare smooth, particulate suspensions for use as
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antigens in serologic tests. These suspensions, because of surface-
mass relationships, are less sensitive than the ordinary bacterial
antigens.
The comparatively slow progress of most fungus infections
allows ample time for the tissues to become hypersensitive to the
fungus or fungus products. Although a negative reaction to
Blastomyces dermatitidis does not exclude the possibility of the
presence of blastomycosis, a positive reaction is diagnostic of the
disease and we have not as yet obtained a positive reaction in
patients with other diseases. In contrast, a skin reaction to a
Gandida (Monilia) vaccine is common in patients who do not have
moniliasis, due presumably to the frequent occurrence of these
fungi in normal patients as well as those suffering from other
diseases.
In the table are listed the serologic findings and the skin re-
actions in 17 cases of American blastomycosis (Gilchrist's disease).
The case labeled "S. C." was not seen in this clinic but the serum
and pus from a subcutaneous abscess were sent to us through the
courtesy of Dr. William H. Kelley of Charleston, S. C. The
diagnosis in every case was confirmed by culture. The techniques
used in performing the complement fixation and skin tests have
been described before (1), except that in some instances both
tests were done with a saline extract of Blastomyces prepared by
grinding the frozen and dried fungi in a ball mill. Patients with
Gilchrist's disease may be divided into 4 clear-cut groups by
classifying them as to their degree of allergy and titer of comple-.
ment fixing antibodies.
We have placed 6 patients in group 1, all of whom had a high
titer of complement fixing antibodies but gave a negative or weak
skin reaction to the intradermal injection of vaccine. The South
Carolina patient was not skin tested, and we have no details con-
ceruing the extent of his disease, other than that he was dis-
charged from the hospital with a hopeless prognosis. Four of the
patients in this group died with generalized disease and the
necropsy findings have been described elsewhere (2). One
patient (W. M.) had blastomycotic lesions on the bridge of his
nose, the right shoulder, and on the large toe of his right foot.
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Although he had no pulmonary symptoms, roentgenographic
study showed a diffuse soft infiltration throughout the upper two-
thirds of both lungs. The x-ray pictures were studied by Dr.
William Wallace, who felt that the lesion resembled fungus in-
fection rather than tuberculosis because of the absence of cavita-
tion. Although we could obtain no sputum for examination,the
TABLE 1
Immunologic findings in 17 cases of blastomycosis
COMPLETE
PATIENT FN LESIONS OUTCOME
PLEMENT
S. D 1:32 Neg. Generalized Died
E. L 1:32 Neg. Generalized Died
V. P 1:16 Neg. Generalized Died
W. M 1:16 Neg. Skin. Later developed ab-
dominal mass
Not known
S. C 1:32 ? No details Death expected
R. H 1:32 1+ Generalized Died
V. S 1:16 2+ Lungs, peritoneum, bones Cured
I. B 1:8 2+ Skin (extensive) Markedly improved
R. R 1:2 3+ Skin (foot) Improved
A. J Neg. 2+ Skin (face) Markedly improved
B. V Neg. 2+ Lungs, subcut. abscess Markedly improved
N. A Neg. 3+ Skin Improved. Recur-
rence 4 years later
H. L Neg. 4+ Skin (localized) Cured
A. Y Neg. 4+ Lungs, subcut. abscesses Markedly improved
P. 5 Neg. Neg. Skin (face) Not followed
G. J Neg. Neg. Skin (face) Died
H. M Neg. Neg. Bones Cured
relatively high titer of complement fixing antibodies (1:16)
suggested that the infection was deep-seated and that the lungs
probably were involved. This patient remained in the hospital
for only a short time and we have no record of his present condi-
tion, but a recent letter from his physician states that the patient
had developed a freely movable abdominal mass in the region of
his umbilicus.
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In group 2 are listed 3 patients who showed some degree of
hypersensitiveness to Blastomyces and who also had some comple-
ment fixing antibodies, as shown by serologic examination. The
patient with the highest titer (V. S.) was remarkable in that she
had extensive lesions involving the lungs, peritoneum, uterus,
Fallopian tubes and vertebrae. She is classified as cured because
she has had no recurrence of the disease 7 years since the onset of
symptoms. Her complement fixation reaction has been negative
since December 1935. This patient was treated with iodides
after a preliminary period of desensitization by small doses of
Blastomyces vaccine. The uterus and both tubes were removed
later (3). The other two patients in this group improved with
vaccine and iodide treatment.
In group 3 are included 5 patients who had no detectable com-
plement fixing antibodies in their serum but who were definitely
allergic to the fungus. All of these patients improved markedly
after vaccine treatment followed by iodides or x-ray. One
patient (H. L.) illustrated beautifully the dangers of iodide
therapy in a patient who is allergic to the fungus. This man
developed fever and the lesion spread violently during the time
that iodides were given; recovery followed the withdrawal of
iodides and the administration of minute doses of vaccine.
Vaccine treatment was continued for a long time before the
patient was able to take iodides without symptoms referable to
the local lesion (4). Another patient (N. A.) was discharged
greatly improved and was not seen again until April 18, 1941, 4
years after his discharge from the hospital. He had taken no
medicine or treatment of any kind and his lesions had all re-
curred. Skin test at this time showed only a 1+ reaction and
his complement fixation test was still negative.
Group 4 comprises 3 patients who gave a negative reaction to
both tests. One remained in the hospital for only two weeks and
the outcome could not be determined. Another patient (G. J.)
with very extensive blastomycosis of the skin, involving the face
and all extremities, gave a negative skin test and a negative
complement fixation reaction. His lungs were not involved.
As he died at home 4 years after the onset of his illness, we have
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no information concerning the lesions at the time of death. The
third patient in this group (H. M.) had two bone lesions and was
of exceptional interest in that his recovery followed administra-
tion of small amounts of serum. He presented an unusual im-
munologic picture in that the skin test was negative despite the
fact that he had had his disease long enough to have developed
an allergic reaction to the fungus. The patient did not present
the clinical picture of an overwhelming infection, and this view
was strengthened by the lack of detectable complement fixing
antibodies in his serum. Since this patient showed no sensi-
tivity to vaccine, iodides were given, but the infection in the bone
of his elbow continued to progress and it was felt that an amputa-
tion of the arm would be necessary. At this time the patient was
tested with an anti-Blastomyces rabbit serum which caused the
formation of an immediate erythematous reaction (Foshay test).
The normal rabbit serum control caused no reaction. Small
increasing doses of rabbit serum were then given and the lesion
began to heal. Maggots were used to help clean away the dead
tissue and improve drainage. Following serum treatment, the
immunologic picture was reversed; the previously negative skin
test to vaccine became positive and, for a short time, complement
fixing antibodies appeared in the blood, but to a maximum titer
of only 1—2. This case record has been published elsewhere
(5) but is included here to emphasize the possibility of serum
treatment in cases showing this unusual immunologic picture.
We realize that it is dangerous to draw conclusions from this
small series of cases, but it is very doubtful if even a much larger
series would yield data sufficiently accurate for statistical analysis,
because of the great variations in the clinical picture, in the dura-
tion of the disease and in the reaction of the host to his infection.
The patients in this series had many forms of therapy including
a good diet, vitamins, potassium iodide, ethyl iodide inhalations,
local applications of tincture of iodine, local applications of copper
sulphate by compress and iontophoresis and varying amounts of
x-ray therapy in addition to surgical intervention in several
cases. However, we feel justified in concluding that the titer of
complement fixing antibodies reflects, within limits, the degree
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of involvement of the patient's tissues. The complement fixing
titer of patients with generalized disease is high and remains high
until death, but widespread skin infections may exist without
sufficient antibody formation to be detected by the relatively
insensitive antigen used in the test. Conversely, a low or nega-
tive antibody titer suggests that involvement of the internal
organs is not widespread. A fall in antibody titer suggests that
the patient is improving, as noticed in case V. S., and also in a
case of chromoblastomycosis seen by us in which the titer of
complement fixing antibodies in the patient's serum decreased
as the clinical lesions improved (6).
We believe that the degree of allergy should be determined
before outlining the course of treatment and that no iodide or
x-ray therapy should be started without preliminary partial de-
sensitization of the patient. In cases giving a negative reaction
to both tests, the prognosis is doubtful. Only two of our 3
patients with these immunologic findings were followed and in
neither of these were iodides of any benefit, yet in one case serum
therapy seemed to initiate recovery. The other patient was seen
before we had prepared an antiserum.
So far we have failed to encounter a falsely positive skin test or
falsely positive complement fixation reaction in patients without
blastomycosis. From the viewpoint of diagnosis, 9 of 17 blasto-
mycotic patients (53 per cent) were positive by complement
fixation, 9 of 16 (56 per cent) were positive by skin test, and 14
of 17 (82 per cent) reacted to one or the other test, or both.
Blastomycosis, therefore, cannot be excluded by negative re-
actions to both tests. However, in patients with evidences of
severe systemic infection such as multiple abscesses and severe
pulmonary or bone lesions of unknown etiology, it is felt that a
negative complement fixation is of definite value in excluding
blastomycotic infection.
The diagnosis of moniliasis is much more difficult to establish
than blastomycosis because of the high incidence of Candida
(Monilia) albicans in the vagina, sputum or feces of normal in-
dividuals or patients obviously not suffering with moniliasis.
Reactions to Monilia vaccines or extracts have little significance
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because of the frequency of skin reactions in patients not suffering
from the infection. Todd (7) has reported that the sera of 22.5
per cent of 1150 normal persons agglutinated Monilia albicans
but of these oniy 35 (3 per cent) gave titers of 1—160 or more.
In our experience agglutination tests have been disappointing
as a method of diagnosis. Sharp agglutinin reactions with these
large cell suspensions are very difficult to read and the clumps
can be broken up easily by vigorous shaking. Moreover, we
have tested some sera from clear-cut cases of pulmonary mo-
niliasis in which agglutinins could not be satisfactorily demon-
strated.
Because of these difficulties, the diagnosis of pulmonary
moniiasis must depend upon the clinical picture, the constant
presence of large numbers of yeastlike organisms in specimens of
sputum, and the absence of other organisms known to cause
chronic lung diseases, i.e. tuberculosis, lung abscess, bronchi-
ectasis, infection with staphylococci or Friedlander's bacilli, etc.
Yeastlike organisms are found so frequently in chronic pul-
monary infections of bacterial origin that some observers con-
sider the fungus to be a secondary invader. We believe, how-
ever, that these organisms are important in the production of
symptoms and the maintenance of infection, regardless of whether
or not they represent the primary etiologic factor of the disease.
A positive skin test to C. albicans is significant in a patient with
pulmonary infection who has C. albicans constantly present in
his sputum. A positive skin test in a patient without disease
has no significance whatever.
One patient, a doctor's wife, was sent to us by Dr. Ezra Bridge
of lola Sanatorium, Rochester, N. Y. She had been well until
October 1933 when she had a coryza followed by a dry cough
which persisted until December of the same year, when the cough
became severe and she began to raise about 1 oz. of yellow sputum
daily. She lost weight, strength and had some dyspnoea on
exertion. Râles were heard in her chest and the x-ray showed a
picture resembling mycotic infection rather than tuberculosis.
She had had more than 50 sputum examinations, all of which
were negative for tubercie bacilli, but C. albicans was isolated in
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a number of instances and identified by Dr. C. M. Carpenter of
Rochester, N. Y. The patient improved with rest in bed but
symptoms recurred if she became active and there was no essential
change in the roentgenologic findings over a period of 2 years.
She came to Duke Hospital in October 1935 as a patient of Dr.
D. T. Smith. Agglutination tests were negative but she gave a
3+ reaction to the intracutaneous injection of vaccine and was
given a series of desensitizing doses of vaccine with rapid im-
provement. She has remained completely well for the past
ft years, except for an occasional "cold" and sinusitis. Her
husband reports that he gives her some vaccine following each
cold as it seems to aid in clearing up the cough.
In contrast to this immunologic picture of hypersensitivity to
the fungus, patients may be encountered who give no reaction
to the intracutaneous injection of vaccine. We have had the
opportunity of studying a patient with pulmonary moniliasis
who was under the care of Dr. E. L. Persons, Duke Hospital.
The patient was extremely hypersensitive to iodides and was
treated with intravenous injections of large amounts of gentian
violet. The patient failed to improve clinically, lost weight and
the roentgenologic examination showed spreading of the disease
process. A Foshay test was positive and anti-C. albicans rabbit
serum was administered. Within a month the patient's lungs
had cleared completely and when seen on April 21, 1941, 6
months after her discharge from the hospital, she was entirely
well, having gained 18.0 kilos (39.6 lbs.) since the time of her
lowest weight 7 months before. Her immunologic picture was
reversed following serum treatment; the agglutination test be-
came positive and the intracutaneous injection of vaccine caused
a small reaction.
SUMMARY
From a study of a limited number of deep-seated fungus in-
fections we have found that the results of serologic examination
are extremely helpful in outlining the course of treatment. A
patient who is hypersensitive to the fungus must be partially
desensitized before any other form of treatment, such as iodides
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or x-ray therapy, is instituted. Even simple surgical procedures,
such as drainage of subcutaneous abscesses, are best deferred
since in our experience draining sinuses are less likely to form if
the patient has had vaccine treatment. If the patient is not
hypersensitive to the fungus, lodides, gentian violet, x-ray
therapy etc., may be instituted. However, these measures must
be initiated cautiously as our knowledge of the disease process is
far from complete. Occasionally a patient may be benefited by
serum therapy. Serologic tests are of value in certain patients
in establishing a diagnosis and are frequently helpful, especially
in blastomycosis, in determining the extent of the disease and the
prognosis.
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DISCUSSION
DR. MARION B. SULZBERGEIL, New York, N. Y.: Although we did not deal with
true blastomycosis, we have studied several cases of moniliasis of the skin and
lungs, and Dr. Hopkins and we have studied some cases of moniliids of the skin.
In the first place, as regards the use of iodides in our cases: the patients, with-
out exception, had an unusual sensitivity to iodides. I do not know whether the
iodides were actually producing iododermas in these cases, because all the patients
had skin lesions which flared up so badly that we had to abandon the use of iodides.
These patients would get lymph node swellings from the iodides as well. We
attempted to desensitize all our cases of systemic moniliasis with repeated small
injections of oidiomycin or monilia extracts, without any beneficial therapeutic
results. All other methods of treatment were ineffectual. All the four cases I
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have in mind were really very distressing and desperate. Of these, two died of
internal moniliasis and one gradually got kidney involvement, and the fourth was
lost track of. So that, if Dr. Martin's serum is going to be of value in these cases
it must be welcomed as meeting a great need.
Dn. NELSON PAUL ANDERSON, Los Angeles: Dr. Hopkins said he did not feel
capable of adding anything; and I feel the same way. I simply wish to speak of
two different types of fungus infections which have responded to this line of ther-
apy. In the southern part of California coccidiodes has a high mortality rate.
Dr. H. P. Jacobson, of Los Angeles, has been very much interested in this disease
for a number of years. He has been treating such cases with vaccine, and he is
able to show results that I have never seen duplicated. I do not say that he has
cured these patients, but I have seen patients with 10, 15 or 20 draining sinuses
from eoccidiodes who appeared to be in the last stages of the disease, in whom the
disease has been arrested. I have seen these people back at work years later.
The second point I wish to make is that there has been a similar occurrence in
aetinomycosis. I have seen instances, particularly aetinomycosis of the liver,
operated on under the mistaken diagnosis of liver abscess, and subsequent perma-
nent fistula present. The disease was progressing unfavorably until the applica-
tion of vaccine therapy, after which it seemed to respond. All these eases had
failed to respond to iodides; and there was dramatic response to vaccine therapy.
I think Dr. Martin is to be congratulated upon really bringing forth a therapeutic
advance in the treatment of a very serious, and very frequently, fatal fungus
infection.
DR. FRED WEIDMAN, Philedelphia: I do not know when there has been pre-
sented such a graphic presentation—one so clear-cut as this. The author began
by intimating that, by and large, not as much is to be expected in the way of anti-
genie responses of practical value in the field of fungi as compared to the realm of
the bacteria. This is true. For a long time we have had available in mycology
only one such procedure of any value, and that is the agglutination test for sporo-
trichosis.
Dr. Martin's success, based on the fact that he has had 17 cases to work with,
is indeed unusual. Then he had the ingenuity to make deductions which have
resulted in the successes he has shown here. I mean this to be complimentary,
and I am sure I voice the opinion of everybody.
I wish to know more about the preparation of the antiserum. I suppose that
he has been using cultures grown on blood agar at incubator temperature from
forms of fungus comparable to the tissue forms, and not from the forms developed
in the culture tubes?
DR. DONALD S. MARTIN, Durham, N. C.: I had hoped that there would not be
too much discussion about the antiserum which is simply an anti-Blastomyces
rabbit serum kept for diagnostic purposes. It is not necessary to isolate a patient
with blastomycosis because of the very slight chance of transmission of the disease
to a normal healthy individual which means that the normal body defense mecha-
nisms are fairly adequate. In California Valley fever the patient takes care of
the primary fungus infection himself, the progressively fatal disease representing
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a secondary infection with the same fungus. It is hard to avoid the feeling that
some untreated cases of blastomycosis would recover if they had not been diag-
nosed and then given iodides. Iodide treatment in the allergic patient (and not
all patients are allergic) may result in extension of the disease. We lost 3 patients
in this manner. The first patient was given iodides and died promptly; another
man who had been in the stationary stage for four years died six weeks after
administration of the drug. We then tried vaccine treatment but only if the
patient was sensitive as shown by skin testing with vaccine. The serum was
used in only one patient because this patient was not allergic to the vaccine but
did react positively to the "Foshay test."
Anti-Monilia serum was made in the same way as the anti-Blastomyces serum
and was used in the only Monilia case we have had who was not sensitive to Mo-
nilia vaccine. That this serum might have any effect on the course of the disease
was considered because this patient had a positive "Foshay test" as shown by
injection of the anti-Monilia serum.
All of our patients have had extensive forms of treatment such as good diet,
bed rest, fluids, iodides, iontophoresis and x-rays. The most important thing
in managing a patient with blastomycosis is for the physician to keep in close
contact with the disease and try these forms of therapy as they are indicated by
the progress of the infection and the serologic and sensitivity tests.
